Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.68 |
| ▸ | FBP1 | P09467 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | IGF2R | P11717 | 4/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HK1 | P19367 | 1/20 | 0.40 |
| ▸ | HK2 | P52789 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20291477 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL14669223 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL4363197 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL20299968 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL29425232 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL25361382 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL4363206 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL20912983 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL20558753 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL14414833 | 0.96 | AMDHD2 (0.62) | AMDHD2FBP1MAPK1IGF2RLGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4560029-A1 | METHOD FOR THE DIAGNOSIS OF ANEURYSM, AND INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF ANEURYSM | Fundacion Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz (ES) | 2025-05-28 | — | — | EP | claimed |
| EP-3338088-B1 | BIOMARKERS FOR CORONARY HEART DISEASE | BGI SHENZHEN (CN) | 2025-01-08 | — | — | EP | claimed |
| CN-116930379-A | Liquid chromatography-mass spectrometry method for detecting hexosamine biosynthesis pathway metabolite | 中国药科大学 | 2023-10-24 | — | — | CN | claimed |
| EP-4216906-A1 | COMPOSITIONS FOR IMPROVED SKIN APPEARANCE AND METHODS OF USE THEREOF | Biogen Stemceuticals, Inc. (US) | 2023-08-02 | — | — | EP | claimed |
| WO-2022067002-A1 | COMPOSITIONS FOR IMPROVED SKIN APPEARANCE AND METHODS OF USE THEREOF | BIOGEN STEMCEUTICALS, INC. (US) | 2022-03-31 | — | — | WO | claimed |
| EP-4731778-A2 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | disclosed |
| US-12540946-B2 | Methods and systems for detecting and quantifying large number of molecule biomarkers from a body fluid sample | COMPLETE OMICS INC. (US) | 2026-02-03 | — | — | US | disclosed |
| EP-4662305-A1 | PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4662224-A1 | PRODUCTION OF A SACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF LACTOBIONIC ACID | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | disclosed |
| US-20250361538-A1 | BACTERIUM, MICROBIAL CONSORTIUM COMPRISING THE SAME AND USES THEREOF | THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (IL) | 2025-11-27 | — | — | US | disclosed |
| EP-4652175-A1 | PURIFICATION OF A SACCHARIDE FROM A FERMENTATION BROTH | Inbiose N.V. (BE) | 2025-11-26 | — | — | EP | disclosed |
| WO-2022096536-A1 | TARGET-CELL RESTRICTED, COSTIMULATORY, BISPECIFIC AND BIVALENT ANTI-CD28 ANTIBODIES | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2022-05-12 | — | — | WO | disclosed |
| EP-3994171-A1 | ANTIBODIES BINDING IGC2 OF IGSF11 (VSIG3) AND USES THEREOF | iOmx Therapeutics AG (DE) | 2022-05-11 | — | — | EP | disclosed |
| CN-114302890-A | Quantification of bioconjugate glycosylation | 葛兰素史克生物有限公司 | 2022-04-08 | — | — | CN | disclosed |
| WO-2022067002-A1 | COMPOSITIONS FOR IMPROVED SKIN APPEARANCE AND METHODS OF USE THEREOF | BIOGEN STEMCEUTICALS, INC. (US) | 2022-03-31 | — | — | WO | disclosed |
| US-11286283-B2 | Immunogenic composition | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-03-29 | — | — | US | disclosed |
| US-11285200-B2 | Modified host cells and hybrid oligosaccharides for use in bioconjugate production | GLAXOSMITHKLINE BIOLOGICALS SA | 2022-03-29 | — | — | US | disclosed |
| WO-2022034076-A2 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
| WO-2022034077-A1 | PRODUCTION OF ALPHA-1,3 GLYCOSYLATED FORM OF FUC-A1,2-GAL-R | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540946-B2 | Methods and systems for detecting and quantifying large number of molecule biomarkers from a body fluid sample | MYADM, EPCAM, CD14 | AMDHD2 2725/4885FBP1 3081/4885MAPK1 4092/4885 |
| US-11286283-B2 | Immunogenic composition | HIRA, HSPA1A, HSPA8 | AMDHD2 309/4885FBP1 3487/4885MAPK1 3573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.